Balversa

Ended Awarded

Contract number
36C26124N0618
Awardee
Awarding agency
Obligated
$22,054

Award facts

Contract value 100% obligated
$22,053.66 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Horsham, PA 19044, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., for the chemotherapy drug BALVERSA (erdafitinib). This order was placed against Janssen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a $3.1 billion multiple award schedule that allows VHA to procure prescription drugs to support veteran healthcare programs. The $22,053.66 delivery order has a completion date of July 30, 2024 and does not have a set-aside designation. Janssen also holds a $3.7 million single award blanket purchase agreement (BPA) under FSS-61-IB that enables VISNs (Veterans Integrated Service Networks) to place orders for BALVERSA and other oncology medications like Belzutifan through July 2024. These contract vehicles facilitate Janssen's role as a prime contractor providing vital pharmaceutical products to VA medical facilities nationwide.

Quick answers

Who was awarded contract 36C26124N0618?

36C26124N0618 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 30, 2024.

How much is contract 36C26124N0618 worth?

The government has obligated $22,054 on 36C26124N0618.

Is contract 36C26124N0618 an order under another contract?

Yes. 36C26124N0618 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26124N0618 competed?

The extent of competition for 36C26124N0618 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award